ArdorComm Media Group

Health & Wellness Community

Honeywell and Narayana Health have partnered to look into co-creating healthcare technologies

Honeywell signed a non-binding memorandum of understanding (MoU) with Narayana Hrudayalaya Limited (Narayana Health) on Thursday in Bengaluru to discover, appraise, and collaborate on prospects for the latter’s digital transformation journey. In a statement, Honeywell said, “This will enable Narayana Health to offer technology-driven, affordable, and accessible healthcare for all.” “The Memorandum of Understanding with Narayana Health, one of India’s leading healthcare service providers, offers us with an opportunity to develop a strategic technology development roadmap that will eventually transform India’s healthcare industry,” said Suresh Venkatarayalu, Honeywell’s Chief Technology Officer. “Sensors and digital technology will disrupt healthcare delivery. Narayana Healthcare is delighted to work with Honeywell to develop digital technologies for making healthcare safer, more accessible, and more affordable, “Dr Devi Prasad Shetty, Chairman and Executive Director of Narayana Health, stated. According to the statement, Honeywell and Narayana Health will collaborate on product innovation and introduction, establish technology development centres, co-create joint capabilities in technology development and research, and develop fire safety codes that ensure an end-to-end life safety system to make hospitals safer.

Honeywell and Narayana Health have partnered to look into co-creating healthcare technologies Read More »

India registers 1,675 COVID-19 cases, 31 deaths

The number of people vaccinated against COVID-19 in India has surpassed 192.52 crore. This was accomplished after 2,42,67,393 sessions. The first dose of the COVID-19 vaccination has been given to almost 3.30 crore adolescents so far. COVID-19 precaution dosage administration for the age group 18-59 years began on April 10, 2022, and will continue until April 10, 2023. In the last 24 hours, 1,635 patients have recovered, bringing the total number of recovered patients to 4,26,00,737. As a result, India’s recovery rate is 98.75 percent. In the previous 24 hours, 1,675 new cases and 31 deaths have been reported. The number of active cases in India is presently 14,841. Active cases now account for 0.03 percent of all positive cases in the country. In the previous 24 hours, 4,07,626 COVID-19 tests were done. India has completed approximately 84.74 crore tests in total. The country’s weekly positivity rate is currently 0.49 percent, with a daily positivity rate of 0.41 percent.

India registers 1,675 COVID-19 cases, 31 deaths Read More »

Government has issued an alert for ports and airports due to an increase in monkeypox cases

India has increased surveillance and ordered its port and airport employees to remain vigilant and isolate sick people travelling from impacted countries who have symptoms or a history of monkeypox. The health ministry has also instructed officials to conduct thorough thermal screenings of suspected foreign travellers who have travelled to monkeypox-affected nations in the previous 21 days. According to official sources, the health ministry has asked the National Center for Disease Control and the Indian Council of Medical Research to keep a close eye on the situation and boost community surveillance in the occurrence of a positive case.

Government has issued an alert for ports and airports due to an increase in monkeypox cases Read More »

First two cases of monkeypox have been confirmed in Canada

The first two cases of monkeypox virus infections in Canada were verified by Canada’s public health ministry on Thursday, after authorities in Quebec province announced they were examining 17 suspected cases.  Monkeypox has been recorded in several countries recently, including Portugal and Spain, with a case in the United States identified by Massachusetts public health officials on Wednesday in a man who had just gone to the Canadian province of Quebec.  “Tonight, the Province of Quebec was notified that two samples received by the NML (National Microbiology Laboratory) have tested positive for monkeypox. These are the first two cases confirmed in Canada,” in a statement, the Public Health Agency of Canada (PHAC) claimed that monkeypox had never been seen in Canada previously. Monkeypox is a rare viral infection that is similar to human smallpox but is milder. It’s most common in western and central Africa. It was first discovered in the 1970s in the Democratic Republic of Congo. In the previous decade, the number of cases in West Africa has grown. Fever, headaches, and skin rashes that begin on the face and progress to the rest of the body are among the symptoms.  Earlier on Thursday, health officials in Montreal, Quebec’s largest city, told reporters that there was a link between a case of monkeypox in Massachusetts and a few suspected cases in the Montreal region. According to the PHAC, a US citizen who recently travelled to Canada by private transportation “may have been infected before or during” his visit to Montreal. Source: Reuters

First two cases of monkeypox have been confirmed in Canada Read More »

Takeda launches hemophilia drug Adynovate in India

Takeda Pharma has expanded its unique rare diseases portfolio in India with the launch of Adynovate, an extended half-life recombinant Factor VIII (rFVIII) medication for haemophilia A patients that uses existing technology (controlled PEGylation). It also stated that Adynovate, when used in conjunction with MYPKFIT, the first and only FDA-approved app, provides a personalised and interactive prophylaxis treatment option that allows both healthcare professionals and patients to monitor factor VIII levels in real time from the comfort of their own homes using a mobile phone. Patients on prophylaxis receive alerts when their predicted factor VIII levels are low, as well as reminders when their infusions are due, ensuring excellent prophylactic coverage. Adynovate, which is administered in three phases with the BAXJECT III system, avoids the requirement for vial disinfection because vials are fully built in the system housing. It can be stored at room temperature for up to three months without exceeding the expiration date, provided that the temperature does not exceed 30°C (86°F). Takeda Pharma has been focused on driving thorough research to enable the development of successful and novel treatments in the company’s chosen therapy areas as a global leader in pharma, according to the corporate statement.

Takeda launches hemophilia drug Adynovate in India Read More »

Tamil Nadu steps up vigil on border as tomato fever spreads in Kerala

After reports of tomato fever or flu spreading among children, the Tamil Nadu health authority has enhanced its vigilance at all checkpoints bordering Kerala. To scan youngsters under the age of five, health, police, and revenue authorities have been stationed at Walayar check post in Palakkad district, Kalliyakavali in Thiruvananthapuram, and Theni check posts. “The tomato flu or fever is a self-limiting one and there are no specific drugs for it,” a senior official with the Tamil Nadu health department told IANS. “If someone is affected with this disease, they should be kept in isolation as it spread fast from one person to the other.” The tomato flu, also known as tomato fever, is characterised by red rashes and blisters, thus the name. This flu causes severe fever and body aches in children under the age of five, as well as blisters and rashes on the skin. Three teams have been deployed at each check post, according to a Tamil Nadu health department official, to prevent children with rashes and blisters from entering the state. Dehydration, stomach pain, diarrhoea, nausea, and vomiting are very common symptoms among infected children. Tomato flu has been reported in numerous districts across Kerala, prompting state health minister Veena George to send a caution about the disease. Source: IANS

Tamil Nadu steps up vigil on border as tomato fever spreads in Kerala Read More »

Indian citizens and students are now eligible for a booster shot, according to the health minister

People travelling overseas can now get Covid booster shots if they need them, according to the Center. This follows NTAGI’s recommendation to reduce the time between the second and third shots for persons travelling abroad. “Indian citizens & students travelling overseas can now take the precaution dose as required by the guidelines of the destination country.” Health Minister Mansukh Mandaviya wrote on Twitter. The National Technical Advisory Group on Immunization (NTAGI) said on Wednesday that those who want to go overseas can shorten the nine-month gap between the second and booster doses of the covid-19 vaccine, as required by the government. The recommendation was later forwarded to the Union Health ministry. Several requests for the precaution dose of Covid vaccine have been received by the Centre in recent months from people who need to travel abroad for work, business, admission to foreign educational institutes, participation in sports events, and bilateral and multilateral meetings as part of India’s official delegation. “The issue was discussed in a meeting of NTAGI held last week after which it recommended that those who need to travel overseas can take the booster shot, before the stipulated nine-month waiting period, as per the booster guidelines of the country they are travelling to,” a source told PTI. Meanwhile, NTAGI is meeting again this week to analyse data for covid-19 immunisation of children aged 5 to 12 years old and to finalise vaccination protocols. The results of the last two meetings were inconclusive, with NTAGI experts remaining sceptical of the paediatric data available for vaccination. Source: Mint

Indian citizens and students are now eligible for a booster shot, according to the health minister Read More »

Medikabazaar has completed a successful test of drone delivery of medical supplies

New Delhi: Medikabazaar is paving the way for the next big thing in healthcare supply chain management by using drones to transport medical supplies to B2B space. In accordance with Medikabazaar’s objective of revolutionising healthcare, the company has started a trial drone project with Redwing Labs to transport medical supplies and evaluate the potential of drones as a last-mile delivery option, particularly in emergency situations. In Bengaluru, the first scheduled test drone delivery was completed successfully. The trial in Bengaluru aimed to deliver medical supplies by drone. The drone in use has a maximum range of 35 kilometres and can transport payloads weighing one to ten kilogrammes. The initiative seeks to provide medical supplies to many places in rural, urban, and semi-urban areas, including those where traditional forms of distribution take much longer due to difficult terrain. Medikabazaar’s pilot initiative seeks to have a large-scale influence and dedication to revolutionise healthcare by making it available to even the most remote locations for emergency situations. Vivek Tiwari, CEO & Founder of Medikabazaar emphasised on the initiative saying, “The ‘Pilot Drone Project’ using drones is in line with our commitment to transform healthcare by way of technology. Faster delivery of critical and emergency medical supplies, vaccines, lifesaving drugs, devices, and equipment can be a great contributor to saving lives. This project is one of the first such programmes in the country where drones are used to deliver medical supplies to hospital centres. The vision is to ensure easy healthcare accessibility throughout the nation, from the most populous to the most remote areas of India in the near future.” In addition, the effort aims to reduce the load on frontline health professionals and supply chain management. Drones that transport medical supplies straight to hospitals save time and assist healthcare staff in providing better patient care. Source: Economic Times

Medikabazaar has completed a successful test of drone delivery of medical supplies Read More »

Eris Lifesciences acquires Oaknet Healthcare for 650cr

Eris Lifesciences Ltd, a branded formulations manufacturer, acquired a 100 percent stake in Mumbai-based Oaknet Healthcare Private Ltd for Rs 650 crore on Tuesday. Oaknet Healthcare specialises in dermatology formulations. Oaknet Healthcare will become a wholly-owned subsidiary of Eris as a result of the acquisition, which will be executed through a share purchase agreement. Eris’ foray into the dermatological segment will be aided by the acquisition, which will allow the company to expand its portfolio, expand its market reach and penetration, and boost its segment ranking. Oaknet Healthcare offers products in dermatology, gynaecology, pain management, nutrition, cardiology, and diabetes, among other segments. “As Oaknet Healthcare becomes part of the Eris Group, it provides us with a robust growth platform in the areas of dermatology and cosmetology,” said Amit Bakshi, CMD, Eris Lifesciences. We are confident that the transaction will create long-term value for our shareholders, in line with the Strides and Zomelis acquisitions.” Eris now has a portfolio of leading dermatological and women’s health brands from Oaknet Healthcare. Oaknet specialises in the production of skincare goods such as moisturisers and anti-fungal creams, among others. “The acquisition of Oaknet brings marquee brands like Cosvate and Cosmelite into the Eris portfolio,” said Krishnakumar V, executive director and chief operating officer of Eris Lifesciences Ltd. We expect to bring to bear multiple value creation levers including in-house manufacturing, new product launches, expansion of field force productivity and enhancement of operational efficiency.” Source: TNN

Eris Lifesciences acquires Oaknet Healthcare for 650cr Read More »

India’s Covid positivity rate past 1 per cent again after two months

According to data published on Monday by the Union Health Ministry, India’s Covid case positivity rate surpassed 1% for the first time in over two months, as the country saw a single-day increase of 3,157 infections and 26 fatalities. According to the data, the increase boosted the country’s entire Covid tally to 4,30,82,345 cases and 5,23,869 deaths. The number of active cases increased by 408 in a 24-hour period to 19,500, according to figures updated at 8 a.m. After a little more than two months, the daily positivity increased to 1.07 percent, according to the ministry. On February 27, it was at 1.11 percent. According to the health ministry, the weekly positivity rate was 0.70 percent. The percentage of all coronavirus tests that yield a positive result is referred to as the positivity rate. A greater positive rate indicates that the virus is spreading more quickly. With the additional 26 fatalities reported, the death toll has now risen to 5,23,869, with 21 of them from Kerala alone. Active cases account for only 0.05 percent of all infections. The COVID-19 recovery rate in the country was 98.74 percent, according to the health ministry. The number of persons who have recovered from the disease has risen to 4,25,38,976, with a 1.22 percent case fatality rate. The total number of doses given out in the country as part of the nationwide COVID-19 vaccination effort has surpassed 189.23 crore. On August 7, 2020, India’s COVID-19 tally surpassed 20 lakh, followed by 30 lakh on August 23, 40 lakh on September 5, and 50 lakh on September 16. On December 19, it exceeded the one-crore mark. On May 4, India passed the two-crore mark, and on June 23, it passed the three-crore mark. Kerala has 21 new fatalities, Odisha has two, while Karnataka, Uttar Pradesh, and West Bengal each have one. So far, the country has reported 5,23,869 deaths, including 1,47,843 in Maharashtra, 69,068 in Kerala, 40,102 in Karnataka, 38,025 in Tamil Nadu, 26,175 in Delhi, 23,508 in Uttar Pradesh, and 21,202 in West Bengal. More than 70% of deaths, according to the health ministry, were caused by comorbidities. “Our figures are being reconciled with (those of) the Indian Council of Medical Research,” the ministry wrote on its website, adding that the state-by-state distribution of figures is still being verified and reconciled. Source: PTI

India’s Covid positivity rate past 1 per cent again after two months Read More »